GlassScriptPhysician profile
Mehran Golpariani
NPI 1083806053
$664.67
in general payments reported to CMS, 2019-2025
12 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.98 · 2020: $85.29 · 2021: $65.80 · 2022: $48.15 · 2023: $102 · 2024: $159 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $419.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $124.18 | 2023-2025 | |
| Scilex Pharmaceuticals INC. | $106.16 | 2020-2024 | Ztlido |
| Vertex Pharmaceuticals Incorporated | $100.59 | 2024-2025 | |
| Ibsa Pharma INC. | $60.18 | 2021-2023 | Tirosint, Licart |
| Valinor Pharma, LLC | $52.29 | 2024 | Movantik |
| Redhill Biopharma INC. | $48.33 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $37.64 | 2020-2022 | |
| Allergan, INC. | $35.18 | 2019-2020 | |
| Forte Bio-Pharma LLC | $33.21 | 2025 | Prolate, Tanlor, Nalocet |
| Grt US Holding, INC. | $31.82 | 2022 | |
| Daiichi Sankyo INC. | $18.42 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mehran Golpariani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.